BioLife Solutions (BLFS) Competitors $25.91 +0.83 (+3.31%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$25.91 +0.00 (+0.00%) As of 08/22/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. TMDX, SLNO, NVST, LIVN, WRBY, INSP, PRCT, LQDA, LMAT, and AORTShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Liquidia Technologies (LQDA), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. Its Competitors TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems PROCEPT BioRobotics Liquidia Technologies LeMaitre Vascular Artivion BioLife Solutions (NASDAQ:BLFS) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Does the media refer more to BLFS or TMDX? In the previous week, BioLife Solutions had 2 more articles in the media than TransMedics Group. MarketBeat recorded 8 mentions for BioLife Solutions and 6 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 1.56 beat BioLife Solutions' score of 1.39 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher earnings & valuation, BLFS or TMDX? TransMedics Group has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$82.25M15.09-$20.18M-$0.12-215.92TransMedics Group$531.29M7.69$35.46M$1.9362.10 Do analysts prefer BLFS or TMDX? BioLife Solutions presently has a consensus price target of $31.29, suggesting a potential upside of 20.75%. TransMedics Group has a consensus price target of $123.00, suggesting a potential upside of 2.63%. Given BioLife Solutions' stronger consensus rating and higher probable upside, research analysts clearly believe BioLife Solutions is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78 Is BLFS or TMDX more profitable? TransMedics Group has a net margin of 13.49% compared to BioLife Solutions' net margin of -5.39%. TransMedics Group's return on equity of 28.02% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-5.39% 0.16% 0.14% TransMedics Group 13.49%28.02%8.64% Do institutionals and insiders have more ownership in BLFS or TMDX? 93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 7.0% of TransMedics Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, BLFS or TMDX? BioLife Solutions has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500. SummaryTransMedics Group beats BioLife Solutions on 11 of the 16 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.20B$10.77B$5.75B$9.62BDividend YieldN/A1.87%4.40%4.10%P/E Ratio-215.9021.2531.3026.05Price / Sales15.0929.38432.98193.75Price / Cash204.7124.5537.7358.48Price / Book3.573.519.536.61Net Income-$20.18M$211.77M$3.26B$265.65M7 Day Performance6.45%4.44%2.13%2.02%1 Month Performance15.41%8.85%2.80%-0.31%1 Year Performance2.41%-9.03%30.68%19.06% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.688 of 5 stars$25.91+3.3%$31.29+20.7%+6.0%$1.20B$82.25M-215.90440News CoverageInsider TradeTMDXTransMedics Group2.8397 of 5 stars$125.65-1.5%$123.00-2.1%-30.9%$4.35B$441.54M65.10210News CoveragePositive NewsSLNOSoleno Therapeutics4.5685 of 5 stars$68.09-4.9%$114.30+67.9%+41.1%$3.81BN/A-16.4530News CoverageAnalyst ForecastAnalyst RevisionNVSTEnvista3.8405 of 5 stars$20.75+0.5%$20.92+0.9%+20.6%$3.43B$2.51B64.8312,300LIVNLivaNova1.713 of 5 stars$53.27-0.8%$59.29+11.3%+21.4%$2.93B$1.25B-13.692,900News CoveragePositive NewsAnalyst ForecastWRBYWarby Parker2.2773 of 5 stars$27.38+0.9%$24.06-12.1%+94.9%$2.85B$771.32M-391.093,780Analyst UpgradeINSPInspire Medical Systems4.9394 of 5 stars$88.28+0.6%$165.62+87.6%-48.6%$2.60B$802.80M51.031,246News CoveragePositive NewsShort Interest ↓PRCTPROCEPT BioRobotics3.5403 of 5 stars$40.71-2.1%$74.88+83.9%-48.6%$2.31B$224.50M-26.26430News CoverageLQDALiquidia Technologies3.5287 of 5 stars$27.72+6.8%$31.40+13.3%+178.7%$2.23B$14M-16.3150LMATLeMaitre Vascular2.1806 of 5 stars$95.04-0.9%$98.00+3.1%+16.4%$2.17B$219.86M46.14490Positive NewsAORTArtivion3.5596 of 5 stars$42.810.0%$39.80-7.0%+75.6%$2.02B$388.54M-101.921,600Analyst ForecastInsider Trade Related Companies and Tools Related Companies TransMedics Group Competitors Soleno Therapeutics Competitors Envista Competitors LivaNova Competitors Warby Parker Competitors Inspire Medical Systems Competitors PROCEPT BioRobotics Competitors Liquidia Technologies Competitors LeMaitre Vascular Competitors Artivion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access